CARISMA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.62 USD | +1.25% |
|
-1.22% | -44.71% |
| 05-02 | Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer | CI |
| 04-11 | BTIG Starts Carisma Therapeutics With Buy Rating, $6 Price Target | MT |
Chart calendar Carisma Therapeutics, Inc.
b862f44.BmA1WVrdFoAq8lNLM7faces2KW5mogW2TuXs9o0zgVo.fzB2YT6-L7lJxAMGUPuLK6NDaiA-m2L6H5a1rrVB7D1OVAY2GZxg2HXFFg~62ef0b78828a26a08e0d6de9d1bf5d4c
Upcoming events on Carisma Therapeutics, Inc.
Past events on Carisma Therapeutics, Inc.
| 29/04/2024 19:00 | Chardans Genetic Medicines Cell Therapy Manufacturing Summit |
| 10/04/2024 20:45 | Needham Healthcare Conference |
| 09/04/2024 21:30 | American Association for Cancer Research Meeting - Abstract Number: 5249 |
| 01/04/2024 13:35 | Q4 2023 Earnings Release |
| 06/03/2024 19:50 | TD Cowen Health Care Conference |
| 11/01/2024 19:15 | JPMorgan Healthcare Conference |
| 29/11/2023 19:35 | Evercore ISI HealthCONx Conference |
| 09/11/2023 12:30 | Q3 2023 Earnings Release |
| 03/11/2023 18:30 | Society for Immunotherapy of Cancer Meeting - Oral – 1514 |
| 03/11/2023 16:00 | Society for Immunotherapy of Cancer Meeting - Poster – 389 |
| 03/11/2023 16:00 | Society for Immunotherapy of Cancer Meeting - Poster – 635 |
| 03/11/2023 16:00 | Society for Immunotherapy of Cancer Meeting - Poster – 307 |
| 03/11/2023 16:00 | Society for Immunotherapy of Cancer Meeting - CAR-Macrophages with custom intronic shRNA exhibit enh |
| 03/11/2023 16:00 | Society for Immunotherapy of Cancer Meeting - Engineered Microenvironment Converters |
| 03/11/2023 16:00 | Society for Immunotherapy of Cancer Meeting - Phase 1, First in Human (FIH) study |
| 11/10/2023 00:30 | Cell & Gene Meeting on the Mesa Conference |
| 02/10/2023 18:00 | Chardan Genetic Medicines Conference |
| 27/09/2023 16:00 | Jefferies Cell & Genetic Medicine Summit |
| 19/09/2023 17:00 | CAR T Consortia Conference |
| 13/09/2023 16:25 | Baird Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 14,9 13,5 10.27% | 16,9 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -88,7 -89,7 1.11% | -65,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -86,9 -88,8 2.11% | -62,1 |
|
Net income Million USD | Released Forecast Spread | -61,2 | -86,9 -88,9 2.28% | -58,4 |
|
EPS USD | Released Forecast Spread | -54,7 | -2,59 -2,52 -2.68% | -1,29 |
| Announcement Date | 04/04/23 | 01/04/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,24 3,73 -13.08% | 3,56 3,24 9.77% | 3,83 0,89 330% | 4,29 2,91 47.55% | 4,40 | 4,43 | 4,46 | 4,43 | 2,14 |
|
EBIT Million USD | Released Forecast Spread | -23,0 -17,0 -35.03% | -21,0 -23,6 11.35% | -22,3 -23,4 4.56% | -22,5 -23,4 4.13% | -19,5 | -14,3 | -12,9 | -12,6 | -11,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -24,5 -18,4 -33.12% | -19,8 -22,8 13.24% | -21,4 -23,0 6.82% | -21,2 -22,9 7.57% | -16,9 | -13,5 | -11,1 | -10,5 | -9,83 |
|
Net income Million USD | Released Forecast Spread | -24,6 -18,4 -33.71% | -19,9 -24,0 17.09% | -21,4 -23,0 6.82% | -21,0 -22,9 8.43% | -17,2 | -12,1 | -10,7 | -10,4 | -9,83 |
|
EPS USD | Released Forecast Spread | -1,93 -0,89 -116.85% | -0,49 -0,60 17.88% | -0,53 -0,57 7.02% | -0,48 -0,55 13.12% | -0,43 | -0,33 | -0,28 | -0,27 | -0,36 |
| Announcement Date | 11/05/23 | 10/08/23 | 09/11/23 | 01/04/24 | - | - | - | - | - |
More events
Past sector events for Carisma Therapeutics, Inc.
| 03/05/2024 12:00 | GH RESEARCH PLC: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:02 | ARDELYX, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 02/05/2024 21:00 | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 02/05/2024 16:00 | GENMAB A/S: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | GERON CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CARM Stock
- Calendar Carisma Therapeutics, Inc.
